Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

NCT01580202 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Malignancy
Hepatitis B

Interventions

DRUG: Entecavir
DRUG: Lamivudine

Sponsor

Seoul National University Hospital